ConductScience.org, home

Paper41291196

Root cause analysis investigation of visible particulates in therapeutic protein drug products using morphologically directed Raman spectroscopy.

de Luna IF and 7 others. Sci Rep, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Root cause analysis investigation of visible particulates in therapeutic protein drug products using morphologically directed Raman spectroscopy. Papers, record 41291196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41291196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Root cause analysis investigation of visible particulates in therapeutic protein drug products using morphologically directed Raman spectroscopy.
PubMed
Journal
Sci Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-10-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Luna IFIsabella F
2Telikepalli SNSrivalli N
3Carrier MMichael
4Ripple DDean
5Srinivasan CCharudharshini
6O'Connor TThomas
7Lute SScott
8Bhirde AAshwinkumar

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Spectrum Analysis, RamanMajor topic
RituximabMajor topic
Particulate MatterMajor topic
Humans
Principal Component Analysis

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124219139Advances in biomedical Raman microscopy.Anal Chem2014https://conductscience.org/library/papers/24219139PubMed
225773722Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway.Pharm Res2015https://conductscience.org/library/papers/25773722PubMed
331544876Engaging with Raman Spectroscopy to Investigate Antibody Aggregation.Antibodies (Basel)2018https://conductscience.org/library/papers/31544876PubMed
434619153Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging Methods.J Pharm Sci2022https://conductscience.org/library/papers/34619153PubMed
523233295Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.J Pharm Sci2013https://conductscience.org/library/papers/23233295PubMed
636058445Morphological integrity of insulin amyloid-like aggregates depends on preparation methods and post-production treatments.Eur J Pharm Biopharm2022https://conductscience.org/library/papers/36058445PubMed
734008082A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.AAPS J2021https://conductscience.org/library/papers/34008082PubMed
818704929Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.J Pharm Sci2009https://conductscience.org/library/papers/18704929PubMed
932104459Effects of granulation process variables on the physical properties of dosage forms by combination of experimental design and principal component analysis.Asian J Pharm Sci2019https://conductscience.org/library/papers/32104459PubMed
1015325292Identification of insulin variants using Raman spectroscopy.Anal Biochem2004https://conductscience.org/library/papers/15325292PubMed
1118937372Quantitation of protein particles in parenteral solutions using micro-flow imaging.J Pharm Sci2009https://conductscience.org/library/papers/18937372PubMed
1211064376Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy.J Pharm Sci2001https://conductscience.org/library/papers/11064376PubMed
1322735943Therapeutic proteins.Methods Mol Biol2012https://conductscience.org/library/papers/22735943PubMed
1431209163Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals.PDA J Pharm Sci Technol2019https://conductscience.org/library/papers/31209163PubMed
1531732691Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach.PDA J Pharm Sci Technol2020https://conductscience.org/library/papers/31732691PubMed
1628848398Microglia Morphological Categorization in a Rat Model of Neuroinflammation by Hierarchical Cluster and Principal Components Analysis.Front Cell Neurosci2017https://conductscience.org/library/papers/28848398PubMed
1733076108Identification of polystyrene nanoplastics using surface enhanced Raman spectroscopy.Talanta2021https://conductscience.org/library/papers/33076108PubMed
1836526853An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards.AAPS PharmSciTech2022https://conductscience.org/library/papers/36526853PubMed
1917025268Effects of protein aggregates: an immunologic perspective.AAPS J2006https://conductscience.org/library/papers/17025268PubMed
2029974414Illicit and Counterfeit Drug Analysis by Morphologically Directed Raman Spectroscopy.Methods Mol Biol2018https://conductscience.org/library/papers/29974414PubMed

See all 33 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42467318Quality by Design to Mitigate Aggregation: Mechanistic Insights and Analytical Strategies for Biopharmaceutical Manufacturing.Ther Innov Regul Sci2026https://conductscience.org/library/papers/42467318PubMed
41544820Optical imaging and spectroscopic characterization of subvisible particles in protein therapeutics.Adv Drug Deliv Rev2026https://conductscience.org/library/papers/41544820PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41291196

GET https://conductscience.org/api/papers/v1/41291196/references?page=2